Home
/
IDEAYA Biosciences, Inc.
/
Financials
/
Quarterly
IDEAYA Biosciences, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that IDEAYA Biosciences, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$207.83M
Nov 4, 2025
Q3
2024
Sep 30, 2024
$0
Nov 4, 2024
Q2
2024
Jun 30, 2024
$0
Aug 6, 2024
Q1
2024
Mar 31, 2024
$0
May 7, 2024
Q3
2024
Sep 30, 2023
$8.04M
Nov 4, 2024
Q2
2024
Jun 30, 2023
$3.54M
Aug 6, 2024
Q1
2024
Mar 31, 2023
$7.88M
May 7, 2024
Q3
2023
Sep 30, 2022
$29.70M
Nov 7, 2023
Q2
2023
Jun 30, 2022
$5.85M
Aug 10, 2023
Q1
2023
Mar 31, 2022
$11.36M
May 9, 2023
Q3
2022
Sep 30, 2021
$8.98M
Nov 8, 2022
Q2
2022
Jun 30, 2021
$8.76M
Aug 15, 2022
Q1
2022
Mar 31, 2021
$7.25M
May 10, 2022
Q3
2021
Sep 30, 2020
$8.97M
Nov 15, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$119.24M
Nov 4, 2025
Q2
2025
Jun 30, 2025
($77.49M)
Aug 5, 2025
Q1
2025
Mar 31, 2025
($72.18M)
May 6, 2025
Q3
2025
Sep 30, 2024
($51.82M)
Nov 4, 2025
Q2
2025
Jun 30, 2024
($52.77M)
Aug 5, 2025
Q1
2025
Mar 31, 2024
($39.57M)
May 6, 2025
Q3
2024
Sep 30, 2023
($27.44M)
Nov 4, 2024
Q2
2024
Jun 30, 2023
($27.93M)
Aug 6, 2024
Q1
2024
Mar 31, 2023
($23.64M)
May 7, 2024
Q3
2023
Sep 30, 2022
$1.62M
Nov 7, 2023
Q2
2023
Jun 30, 2022
($22.06M)
Aug 10, 2023
Q1
2023
Mar 31, 2022
($14.01M)
May 9, 2023
Q3
2022
Sep 30, 2021
($11.58M)
Nov 8, 2022
Q2
2022
Jun 30, 2021
($10.95M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($9.02M)
May 10, 2022
Q3
2021
Sep 30, 2020
($4.93M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($12.39M)
Aug 10, 2021
Q1
2021
Mar 31, 2020
($12.04M)
May 10, 2021
Q3
2020
Sep 30, 2019
($10.97M)
Nov 12, 2020
Q2
2020
Jun 30, 2019
($10.66M)
Aug 12, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$108.45M
Nov 4, 2025
Q2
2025
Jun 30, 2025
($88.81M)
Aug 5, 2025
Q1
2025
Mar 31, 2025
($84.39M)
May 6, 2025
Q3
2025
Sep 30, 2024
($66.89M)
Nov 4, 2025
Q2
2025
Jun 30, 2024
($64.93M)
Aug 5, 2025
Q1
2025
Mar 31, 2024
($51.02M)
May 6, 2025
Q3
2024
Sep 30, 2023
($33.53M)
Nov 4, 2024
Q2
2024
Jun 30, 2023
($32.71M)
Aug 6, 2024
Q1
2024
Mar 31, 2023
($26.28M)
May 7, 2024
Q3
2023
Sep 30, 2022
$660.0K
Nov 7, 2023
Q2
2023
Jun 30, 2022
($22.50M)
Aug 10, 2023
Q1
2023
Mar 31, 2022
($14.22M)
May 9, 2023
Q3
2022
Sep 30, 2021
($11.71M)
Nov 8, 2022
Q2
2022
Jun 30, 2021
($11.05M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($9.14M)
May 10, 2022
Q3
2021
Sep 30, 2020
($5.00M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($12.59M)
Aug 10, 2021
Q1
2021
Mar 31, 2020
($12.48M)
May 10, 2021
Q3
2020
Sep 30, 2019
($11.62M)
Nov 12, 2020
Q2
2020
Jun 30, 2019
($11.24M)
Aug 12, 2020